At a glance
- Originator Eli Lilly and Company
- Class Antiallergics; Antiasthmatics; Quinolines; Small molecules; Tetrazoles
- Mechanism of Action Leukotriene D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
Most Recent Events
- 26 Jun 1998 No-Development-Reported for Asthma (Unknown route)